Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Limited Patient Cohort Follow-up Study to Assess the Long-term Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses in Bilateral Cataract Surgery

NCT06192901 is registered in ClinicalTrials.gov with Carl Zeiss Meditec AG as lead sponsor.

NCT NCT06192901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06192901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Limited Patient Cohort Follow-up Study to Assess the Long-term Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses in Bilateral Cataract Surgery
Lead sponsor
Carl Zeiss Meditec AG
Phase
Observational
Overall status
Completed
Start date
September 18, 2023
Completion date
September 22, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

senile cataract